TenX Keane Acquisition (TENK) Stock Price, News & Analysis
Ticker history: TENK became CTOR (Citius Oncology, Inc.) on . Earlier news and filings retain their original names and dates. View TENK history.
Price Move History
- Daily moves over 5%
- 5 252 sessions, August 11, 2023 to August 12, 2024
- Largest daily move
- +192.9% close of August 5, 2024
- 1-year change
- +279.6% closing prices, August 11, 2023 to August 12, 2024
- 1-month change
- +255% closing prices, July 12, 2024 to August 12, 2024
Company Description
TenX Keane Acquisition (NASDAQ: TENK) is classified in the pharmaceutical preparations industry.
TENK gained 279.6% in the 12 months to August 12, 2024. The last closing price was $40.50.
This page collects what Stock Titan holds for TENK, including price data and latest news.
Stock Performance
TenX Keane Acquisition (TENK) closed at $40.50 on August 12, 2024. In the 12 months to August 12, 2024, the price gained 279.6%.
TENK Metrics & Rankings
Price returns through August 12, 2024. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
TenX Keane Acquisition has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings. View all TENK news →
SEC Filings
TENK Company Profile & Sector Positioning
TenX Keane Acquisition (TENK) and is listed on the NASDAQ.